1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. NEWBORN SCREENING MARKET, BY TECHNOLOGY
5.1. Introduction
5.2. Immune Assays & Enzymatic Assays
5.3. Tandem Mass Spectrometry
5.4. Molecular Assays
5.5. Hearing Screening Technologies
5.6. Others
6. NEWBORN SCREENING MARKET, BY TEST
6.1. Introduction
6.2. Dry Blood Spot Tests
6.3. Hearing Screening Tests
6.4. CCHD Screening Tests
7. NEWBORN SCREENING MARKET, BY END-USER
7.1. Introduction
7.2. Clinical Laboratories
7.3. Hospitals
8. NEWBORN SCREENING MARKET, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. The Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Perkin Elmer
10.2. Trivitron Healthcare
10.3. LifeCell International
10.4. Bio-Rad
10.5. Apollo Cradle
10.6. Nemours Children’s Health
10.7. March for Dimes
10.8. Cure SMA
10.9. Igenomix India